Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13135366 | 0.92 | USP2 (0.48) | USP2LMNAALDH1A1KDM4ETDP1 | |
| Isobutane SCHEMBL27997158 | 0.87 | USP2 (0.52) | USP2LMNAALDH1A1KDM4ETDP1 | |
| Isopropyl Alcohol SCHEMBL7787253 | 0.87 | USP2 (0.52) | USP2LMNAALDH1A1KDM4ETDP1 | |
| SCHEMBL9394354 | 0.87 | TSHR (0.43) | USP2TDP1HSD17B10TSHR | |
| Hydrogen Sulfide SCHEMBL28328118 | 0.87 | LMNA (0.50) | USP2LMNAALDH1A1KDM4ETSHR | |
| SCHEMBL5198804 | 0.86 | USP2 (0.48) | USP2LMNAALDH1A1KDM4ETDP1 | |
| SCHEMBL18484718 | 0.85 | USP2 (0.44) | USP2LMNAALDH1A1KDM4EHSD17B10 | |
| Propylene Glycol SCHEMBL2236346 | 0.84 | TDP1 (0.56) | USP2LMNAALDH1A1KDM4ETDP1 | |
| SCHEMBL15358596 | 0.84 | TSHR (0.41) | TDP1HSD17B10TSHR | |
| Ethane SCHEMBL2303498 | 0.84 | USP2 (0.54) | USP2LMNAALDH1A1KDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3337838-B1 | POLYURETHANE FLEXIBLE FOAMS WITH INCREASED HARDNESS | EVONIK OPERATIONS GMBH (DE) | 2023-06-21 | — | — | EP | disclosed |
| EP-3331491-B1 | POLYMERS DERIVED FROM AMINO-FUNCTIONAL VINYL ALCOHOL ETHERS AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2022-03-23 | — | — | EP | disclosed |
| EP-3219738-B1 | PRODUCTION OF VISCOELASTIC POLYURETHANE SYSTEMS USING BLOCK POLYMERS HAVING LINKED SILOXANE BLOCKS AS CELL-OPENING AGENTS | EVONIK OPERATIONS GMBH (DE) | 2020-04-29 | — | — | EP | disclosed |
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | BASF SE (DE) | 2018-08-02 | — | — | US | disclosed |
| CN-108349225-A | BIREFRINGENT BANKNOTE FILM | 伊诺维亚薄膜有限公司 | 2018-07-31 | — | — | CN | disclosed |
| EP-3067343-B1 | Antioxidants for the preparation of low-emission polyurethane systems | EVONIK DEGUSSA GMBH (DE) | 2018-07-25 | — | — | EP | disclosed |
| EP-3337838-A1 | PRODUCTION OF POLYURETHANE SOFT FOAMS WITH IMPROVED HARDNESS | Evonik Degussa GmbH (DE) | 2018-06-27 | — | — | EP | disclosed |
| WO-2017198545-A1 | (PER)FLUOROPOLYETHER DERIVATIVES | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2017-11-23 | — | — | WO | disclosed |
| EP-3219738-A1 | PRODUCTION OF VISCOELASTIC POLYURETHANE SYSTEMS USING BLOCK POLYMERS HAVING LINKED SILOXANE BLOCKS AS CELL-OPENING AGENTS | Evonik Degussa GmbH (DE) | 2017-09-20 | — | — | EP | disclosed |
| WO-2017029054-A1 | PRODUCTION OF POLYURETHANE SOFT FOAMS WITH IMPROVED HARDNESS | EVONIK DEGUSSA GMBH (DE) | 2017-02-23 | — | — | WO | disclosed |
| EP-3067343-A1 | Antioxidants for the preparation of low-emission polyurethane systems | Evonik Degussa GmbH (DE) | 2016-09-14 | — | — | EP | disclosed |
| EP-3067376-A1 | Production of polyurethane systems using polyether polycarbonate polyols | Evonik Degussa GmbH (DE) | 2016-09-14 | — | — | EP | disclosed |
| EP-2998333-A1 | PRODUCTION OF VISCOELASTIC POLYURETHANE SYSTEMS USING BLOCK POLYMERS HAVING LINKED SILOXANE BLOCKS AS CELL-OPENING AGENTS | Evonik Degussa GmbH (DE) | 2016-03-23 | — | — | EP | disclosed |
| EP-2646491-B1 | TRIAZINE DERIVATIVE | SOLVAY SPECIALTY POLYMERS IT (IT) | 2016-01-27 | — | — | EP | disclosed |
| EP-2197939-B1 | PROCESS FOR THE MANUFACTURE OF POLYOL PERFLUOROPOLYETHER DERIVATIVE | SOLVAY SPECIALTY POLYMERS IT (IT) | 2012-07-11 | — | — | EP | disclosed |
| US-5374486-A | Containing tertiary amine or ammonium components; polyurethane foams | MILES INC. (US) | 1994-12-20 | — | — | US | disclosed |
| EP-0617710-A1 | ISOCYANATE-TRIMERIZATION CATALYST | BAYER AG (DE) | 1994-10-05 | — | — | EP | disclosed |
| WO-1993012153-A1 | ISOCYANATE-TRIMERIZATION CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 1993-06-24 | — | — | WO | disclosed |
| US-4518522-A | DI-(ALKYL OR ALKOXYALKYL) MALONATES AND CONTAINING A STABILIZING MONOFUNCTIONAL REACTIVE COMPOUND | MOBAY CHEMICAL CORPORATION (US) | 1985-05-21 | — | — | US | disclosed |
| US-4235976-A | Use of phosphonates as trimerization catalysts for the production of polyisocyanurate synthetic resins | BAYER AKTIENGESELLSCHAFT (DE) | 1980-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | CBR1, NR0B1, NR0B2 | USP2 4690/4885LMNA 1408/4885ALDH1A1 1733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.